Anticancer agent 109 is an inhibitor of the Gas6-Axl axis with anticancer activity; it suppresses the expression of Gas6 and Axl, inhibits the expression of p-PI3K and p-AKT, induces G1 cell cycle arrest, promotes apoptosis, and significantly inhibits tumor growth in xenograft mouse models.